首页> 美国卫生研究院文献>Frontiers in Chemistry >Small-Molecule Binding Aptamers: Selection Strategies Characterization and Applications
【2h】

Small-Molecule Binding Aptamers: Selection Strategies Characterization and Applications

机译:小分子结合适体:选择策略表征和应用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aptamers are single-stranded, synthetic oligonucleotides that fold into 3-dimensional shapes capable of binding non-covalently with high affinity and specificity to a target molecule. They are generated via an in vitro process known as the Systematic Evolution of Ligands by EXponential enrichment, from which candidates are screened and characterized, and then used in various applications. These applications range from therapeutic uses to biosensors for target detection. Aptamers for small molecule targets such as toxins, antibiotics, molecular markers, drugs, and heavy metals will be the focus of this review. Their accurate detection is needed for the protection and wellbeing of humans and animals. However, the small molecular weights of these targets, including the drastic size difference between the target and the oligonucleotides, make it challenging to select, characterize, and apply aptamers for their detection. Thus, recent (since 2012) notable advances in small molecule aptamers, which have overcome some of these challenges, are presented here, while defining challenges that still exist are discussed.
机译:适体是单链的合成寡核苷酸,其折叠成能够以高亲和力和特异性非共价结合至靶分子的3维形状。它们通过称为“配体系统进化的配体系统富集”的体外过程生成,从中筛选和表征候选物,然后用于各种应用。这些应用范围从治疗用途到用于目标检测的生物传感器。针对小分子靶标(例如毒素,抗生素,分子标记,药物和重金属)的适体将是本综述的重点。为了保护人类和动物的健康,需要对其进行精确检测。然而,这些靶标的小分子量,包括靶标和寡核苷酸之间的巨大尺寸差异,使得选择,表征和应用适体来检测它们具有挑战性。因此,在此介绍了克服了这些挑战中的一些挑战的小分子适体的最新进展(自2012年以来),同时讨论了仍然存在的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号